v::ROS1
About
Gene context: ROS1
Biomarker Type: Rearrangement
Present: True
Rearrangement Type: Fusion
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | v::ROS1 | Non-Small Cell Lung Cancer | Repotrectinib | HC |
| Sensitivity (+) | v::ROS1 | Non-Small Cell Lung Cancer | Repotrectinib | FDA |
| Sensitivity (+) | v::ROS1 | Non-Small Cell Lung Cancer | Crizotinib | FDA |
| Sensitivity (+) | v::ROS1 | Non-Small Cell Lung Cancer | Entrectinib | FDA |
| Sensitivity (+) | v::ROS1 | Non-Small Cell Lung Cancer | Entrectinib | HC |
| Sensitivity (+) | v::ROS1 | Non-Small Cell Lung Cancer | Crizotinib | HC |
| Sensitivity (+) | v::ROS1 | Non-Small Cell Lung Cancer | Taletrectinib | FDA |